Perrigo (PRGO) PT Set at $107.00 by Cantor Fitzgerald

Perrigo (NYSE:PRGO) has been given a $107.00 target price by equities research analysts at Cantor Fitzgerald in a report issued on Friday. The brokerage currently has a “buy” rating on the stock. Cantor Fitzgerald’s target price would suggest a potential upside of 16.90% from the stock’s current price.

PRGO has been the subject of a number of other research reports. Royal Bank of Canada raised shares of Perrigo from an “underperform” rating to a “sector perform” rating and boosted their target price for the stock from $64.00 to $86.00 in a research report on Friday, November 10th. Jefferies Group set a $71.00 target price on shares of Perrigo and gave the stock a “hold” rating in a research report on Sunday, October 29th. UBS Group reissued a “buy” rating and set a $98.00 target price (up previously from $84.00) on shares of Perrigo in a research report on Thursday, October 5th. Deutsche Bank boosted their target price on shares of Perrigo from $88.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, September 14th. Finally, Canaccord Genuity set a $100.00 target price on shares of Perrigo and gave the stock a “buy” rating in a research report on Tuesday, December 26th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $92.00.

Shares of Perrigo (NYSE PRGO) traded down $0.46 during trading hours on Friday, reaching $91.53. 222,006 shares of the company were exchanged, compared to its average volume of 1,063,088. The company has a market capitalization of $12,960.00, a PE ratio of -9.99, a PEG ratio of 1.92 and a beta of 0.64. Perrigo has a 12-month low of $63.68 and a 12-month high of $92.16. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.72 and a quick ratio of 1.24.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Thursday, November 9th. The company reported $1.39 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.28. The firm had revenue of $1.22 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Perrigo had a negative net margin of 26.28% and a positive return on equity of 11.60%. Perrigo’s revenue for the quarter was down 2.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.65 earnings per share. equities analysts anticipate that Perrigo will post 4.88 earnings per share for the current year.

In other news, EVP John Wesolowski sold 450 shares of the company’s stock in a transaction dated Thursday, December 7th. The shares were sold at an average price of $83.09, for a total transaction of $37,390.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Todd W. Kingma sold 1,500 shares of the company’s stock in a transaction dated Friday, December 28th. The shares were sold at an average price of $88.52, for a total transaction of $132,780.00. Following the transaction, the vice president now directly owns 19,565 shares of the company’s stock, valued at approximately $1,731,893.80. The disclosure for this sale can be found here. Insiders have sold 4,051 shares of company stock valued at $355,370 in the last ninety days. 6.90% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in Perrigo by 2.1% in the second quarter. Vanguard Group Inc. now owns 14,874,096 shares of the company’s stock valued at $1,123,292,000 after acquiring an additional 299,328 shares during the period. State Street Corp increased its stake in Perrigo by 1.7% in the second quarter. State Street Corp now owns 6,757,086 shares of the company’s stock valued at $510,294,000 after acquiring an additional 112,287 shares during the period. Greenlight Capital Inc. increased its stake in Perrigo by 14.8% in the third quarter. Greenlight Capital Inc. now owns 2,901,032 shares of the company’s stock valued at $245,572,000 after acquiring an additional 374,032 shares during the period. Parnassus Investments CA increased its stake in Perrigo by 7.1% in the third quarter. Parnassus Investments CA now owns 2,257,000 shares of the company’s stock valued at $191,055,000 after acquiring an additional 150,000 shares during the period. Finally, Goldman Sachs Group Inc. increased its stake in Perrigo by 18.2% in the second quarter. Goldman Sachs Group Inc. now owns 1,975,965 shares of the company’s stock valued at $149,224,000 after acquiring an additional 304,950 shares during the period. 83.29% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This news story was first reported by American Banking and Market News and is owned by of American Banking and Market News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/12/perrigo-prgo-pt-set-at-107-00-by-cantor-fitzgerald-2.html.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Analyst Recommendations for Perrigo (NYSE:PRGO)